A perfect key to success by these 000-052 braindumps

If you really to show your professionalism so just Passing the 000-052 exam is not sufficient. You should have enough Collaborative Lifecycle Management V4 Exam knowledge that will help you work in real world scenarios. Killexams.com specially focus to improve your knowledge about 000-052 objectives so that you not only pass the exam, but really get ready to work in practical environment as a professional.

Exam Code: 000-052 Practice test 2022 by Killexams.com team
Collaborative Lifecycle Management V4 test
IBM Collaborative health
Killexams : IBM Collaborative health - BingNews https://killexams.com/pass4sure/exam-detail/000-052 Search results Killexams : IBM Collaborative health - BingNews https://killexams.com/pass4sure/exam-detail/000-052 https://killexams.com/exam_list/IBM Killexams : IBM Bids Farewell to Watson Health Assets

IBM shook up the digital health space Friday with the news that it is selling its healthcare data and analytics assets, currently part of the Watson Health business, to an investment firm. The sale price is reportedly more than $1 billion, although the companies are not officially disclosing the financial terms.

There are a lot of interesting factors to consider as we unpack this news, although some thought leaders say the divestiture did not come as a surprise.

“The Watson Health sale has been anticipated for quite some time. IBM was clearly not gaining much traction in the healthcare market while others such as Google and Microsoft have pulled ahead. Even Oracle has made a big splash in healthcare with its latest announcement to acquire Cerner," said Paddy Padmanabhan, founder and CEO of Damo Consulting, a growth strategy and digital transformation advisory firm that works with healthcare and technology companies.

IBM was one of the first big tech companies to dive into healthcare with its well-known Watson Health supercomputer known for defeating the greatest champions on “Jeopardy!" The platform created a lot of buzz back in 2011, and many people had high hopes for the platform's potential applications in healthcare. In latest years, however, that buzz has significantly died down.

"In the current competitive landscape, IBM would not be considered a significant player in healthcare. Selling off the data assets essentially means an end to the Watson Health experiment; however, it may allow IBM as an organization to refocus and develop a new approach to healthcare,” Padmanabhan said.

Assuming there are no regulatory snags, the deal is expected to close in the second quarter of this year.

“Today’s agreement with Francisco Partners is a clear next step as IBM becomes even more focused on our platform-based hybrid cloud and AI strategy,” said Tom Rosamilia, senior vice president of IBM Software. “IBM remains committed to Watson, our broader AI business, and to the clients and partners we support in healthcare IT. Through this transaction, Francisco Partners acquires data and analytics assets that will benefit from the enhanced investment and expertise of a healthcare industry focused portfolio.”

The agreement calls for the current management team to continue in similar roles in the new standalone company, serving existing clients in life sciences, provider, imaging, payer and employer, and government health and human services sectors.

“We have followed IBM’s journey in healthcare data and analytics for a number of years and have a deep appreciation for its portfolio of innovative healthcare products,” said Ezra Perlman, co-president at Francisco Partners. “IBM built a market-leading team and provides its customers with mission critical products and outstanding service.”

In 2016 IBM doubled the size of its Watson Health business through the $2.6 billion acquisition of Truven Health Analytics. Truven offers healthcare data services targeted at employers, hospitals, and drug companies, and makes software that can parse through millions of patient records. Truven's main offices are in Ann Arbor, MI, Chicago, and Denver. At the time of the acquisition, Truven had around 2,500 employees.

The Truven deal followed other major healthcare acquisitions in the company, including Cleveland-based Explorys, Dallas-based Phytel, and Chicago-based Merge Healthcare. The company paid about $1 billion for Merge.

IBM said the assets acquired by Francisco Partners include extensive and diverse data sets and products, including Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex, and imaging software offerings.

Padmanabhan said it will be interesting to see how the new owners are able to leverage those data assets.

“IBM’s decision to sell its data assets is an indication that it’s not just enough to have the data. Applying advanced analytics on the data to generate insights that can make a difference in real-world applications is where the true value lies. IBM had several missteps early on, especially in cancer care applications, that created significant setbacks for the business that they could not recover from.

In 2018, the Watson Health business went through a round of layoffs. The company declined to tell MD+DI at the time how many of employees were let go other than to say it was a "small percentage" of the global business, but online commenters on TheLayoff.com and Watching IBM, along with multiple news reports citing unnamed sources from within the organization painted a different picture of the situation. One Dallas-based commenter on TheLayoff.com said that "we all knew it was coming but nobody expected it to be this fast and rampant," while another commenter estimated that 80% of that same Dallas-based office was let go.

Is healthcare just too hard for big tech?

While we have seen a trend in latest years with big tech firms showing an interest in healthcare, some of those companies are finding those efforts to be easier said than done. 
“IBM’s decision to sell the Watson Health assets is another instance of a big tech firm acknowledging the challenges of the healthcare space. Last year, Google and Apple had significant setbacks, and Amazon has acknowledged challenges in scaling its Amazon Care business," Padmanabhan said. "In IBM’s case, they have missed out on the cloud opportunity and have lagged behind peers in emerging technology areas such as voice. While IBM’s challenges with Watson Health may have been unique to the organization, the fact is that big tech firms have multiple irons in the fire at any time, and for some healthcare may just be too hard.”

Padmanabhan does not think, however, that IBM's decision to sell the Watson Health assets is an indictment of the promise of AI in healthcare.

"Our research indicates AI was one of the top technology investments for health systems in 2021," he said. "Sure, there are challenges such as data quality and bias in the application of AI in the healthcare context, but by and large there has been progress with AI in healthcare. The emergence of other players, notably Google with its Mayo Partnership, or Microsoft with its partnership with healthcare industry consortium Truveta are strong indicators of progress."
Padmanabhan is co-author with Edward W. Marx, of Healthcare Digital Transformation: How Consumerism, Technology and Pandemic are Accelerating the Future (2020), and the host of The Big Unlock, a podcast focusing on healthcare digital transformation.

Wed, 12 Oct 2022 12:00:00 -0500 en text/html https://www.mddionline.com/artificial-intelligence/ibm-bids-farewell-watson-health-assets
Killexams : Population Health Management Market Growing Massively by IBM, Optumhealth, Cerner

New Jersey, United States, Oct. 13, 2022 /DigitalJournal/ The Population Health Management Market research report provides all the information related to the industry. It gives the markets outlook by giving authentic data to its client which helps to make essential decisions. It gives an overview of the market which includes its definition, applications and developments, and manufacturing technology. This Population Health Management market research report tracks all the latest developments and innovations in the market. It gives the data regarding the obstacles while establishing the business and guides to overcome the upcoming challenges and obstacles.

Population health management refers to the process of improving the clinical health outcomes of a defined group of people through better coordination of care and patient engagement supported by appropriate financial and care models. The medical industry is rapidly transforming from a paper-based system to a digitized system, accelerating the demand for healthcare IT services. In addition, the growing demand for solutions that support value-based care delivery by healthcare stakeholders has resulted in a shift from fee-for-service (FFS) models to fee-based payment models. value (VBP). Increasing demand for effective disease management strategies is also expected to drive market growth.

Get the PDF trial Copy (Including FULL TOC, Graphs, and Tables) of this report @:


Competitive landscape:

This Population Health Management research report throws light on the major market players thriving in the market; it tracks their business strategies, financial status, and upcoming products.

Some of the Top companies Influencing this Market include:IBM, Optumhealth, Cerner, Healthagen, Verscend Technologies, I2I Population Health, Epic, Orion Health, Forward Health, Change Healthcare, GSI Health, EClinicalWorks,

Market Scenario:

Firstly, this Population Health Management research report introduces the market by providing an overview that includes definitions, applications, product launches, developments, challenges, and regions. The market is forecasted to reveal strong development by driven consumption in various markets. An analysis of the current market designs and other basic characteristics is provided in the Population Health Management report.

Regional Coverage:

The region-wise coverage of the market is mentioned in the report, mainly focusing on the regions:

  • North America
  • South America
  • Asia and Pacific region
  • Middle East and Africa
  • Europe

Segmentation Analysis of the market

The market is segmented based on the type, product, end users, raw materials, etc. the segmentation helps to deliver a precise explanation of the market

Market Segmentation: By Type

Software, Services,

Market Segmentation: By Application

Payers, Providers, Employers,

For Any Query or Customization: https://a2zmarketresearch.com/ask-for-customization

An assessment of the market attractiveness about the competition that new players and products are likely to present to older ones has been provided in the publication. The research report also mentions the innovations, new developments, marketing strategies, branding techniques, and products of the key participants in the global Population Health Management market. To present a clear vision of the market the competitive landscape has been thoroughly analyzed utilizing the value chain analysis. The opportunities and threats present in the future for the key market players have also been emphasized in the publication.

This report aims to provide:

  • A qualitative and quantitative analysis of the current trends, dynamics, and estimations from 2022 to 2029.
  • The analysis tools such as SWOT analysis and Porter’s five force analysis are utilized, which explain the potency of the buyers and suppliers to make profit-oriented decisions and strengthen their business.
  • The in-depth market segmentation analysis helps identify the prevailing market opportunities.
  • In the end, this Population Health Management report helps to save you time and money by delivering unbiased information under one roof.

Table of Contents

Global Population Health Management Market Research Report 2022 – 2029

Chapter 1 Population Health Management Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Population Health Management Market Forecast

Buy Exclusive Report @: https://www.a2zmarketresearch.com/checkout

Contact Us:

Roger Smith


[email protected]

+1 775 237 4157

Thu, 13 Oct 2022 02:11:00 -0500 A2Z Market Research en-US text/html https://www.digitaljournal.com/pr/population-health-management-market-growing-massively-by-ibm-optumhealth-cerner
Killexams : Cleveland Clinic's pathogen center continues its growth

Cleveland Clinic recently received a $2.9 million federal grant to study an emerging tick-borne virus pathogen — the latest funding secured by research occurring within the system's Global Center for Pathogen & Human Health Research.

It's just one of many latest examples of funding awarded to the pathogen center, which houses multidisciplinary research teams working to better understand the response of the human immune system to viral pathogens.

The center, announced in April 2020, took shape at the start of 2021 with the launch of the Cleveland Innovation District. The pathogen center became a cornerstone of the $565 million collaboration among the Clinic, University Hospitals, MetroHealth, Cleveland State University and Case Western Reserve University. The district combines $300 million from the Clinic, $110 million from JobsOhio, and $155 million from the state.

The infusion of funds has allowed the center to invest in building a larger home for its research — most immediately, a renovation and expansion project will add nearly 45,000 square feet to the core Lerner Research Institute building over the next year. Longer term, the Clinic's capital plan includes the addition of two research towers that will house most laboratories on the Clinic's 173-acre main campus.

"And it's more than the space," said Dr. Serpil Erzurum, the Clinic's chief research and academic officer. "It's the partnerships around the city now, right? I mean, we're meeting with University Hospitals regularly. ... That wouldn't have happened without the state investing in us together. And the same with Case Western and Metro now, and Cleveland State."

Dr. Jae Jung, director of the Global Center for Pathogen & Human Health Research, will lead the research team that recently secured the five-year, $2.9 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). They'll study Severe Fever with Thrombocytopenia Syndrome Virus, which the World Health Organization has included on a list of emerging pathogens most likely to cause a future pandemic, according to a news release from the Clinic.

"The goal of the Global Center is we want to prepare for future pandemics," Jung said. "That's the goal, so to do this, actually, No. 1 is that we have to recruit outstanding investigators in many different areas."

Jung has recruited researchers and leaders in immunology, cancer biology, immune-oncology and pathogen research at a "remarkable rate," Erzurum said.

Notable recruits thus far include Dr. Michaela Gack, director of Cleveland Clinic's Florida Research & Innovation Center, and Ted Ross, director of vaccine development, a newly created role.

In 2017 and 2018, Cleveland Clinic averaged $50 million in new awards from NIH, said Erzurum. Because the grants are often paid out over multiyear periods, the new awards each year offer a good metric of annual change. In 2019, that grew to $80 million, and in 2021, the Clinic received $140 million in new awards to its investigators, nearly tripling the figure from just a few years prior.

In 2021, Cleveland Clinic researchers were awarded more than $17 million in NIH grants related to pathogen research into COVID-19 vaccine candidates, development of broad-spectrum antiviral drugs and a vaccine for an emerging tick-borne virus.

"Money means work," Erzurum said. "They're not giving you money just to spend it on frivolous things. We have work to do. ... It's an immense amount of work."

This is why the award from the state of Ohio for the innovation district has helped enable the growth, because it's offered a space for the Clinic's researchers to do their work.

Also supporting the research infrastructure is the Cleveland Clinic BioRepository, which the system and Brooks Automation Inc. opened last year in the Fairfax neighborhood to increase and centralize storage capacity for biologic samples. The 22,000-square-foot facility is a resource for scientists across the region and aims to enhance the research of human tissue samples and ultimately, more rapidly translate laboratory discoveries into new treatments.

Serving as the technology foundation of the pathogen center is the Launched Discovery Accelerator with IBM, a 10-year collaboration to build the infrastructure to support big data medical research. Through the partnership, IBM plans to install and open in early 2023 its first private-sector on-premises IBM Quantum System One in the United States at the Clinic. The rest of IBM's such systems in the country are in its own facilities.

The Clinic is also part of a $577 million NIH research collaborative. NIAID awarded the funds earlier this year to create nine antiviral drug discovery research centers across the country. Jung and Shaun Stauffer, director of the Clinic's Center for Therapeutics Discovery, are working with a multidisciplinary team based out of Scripps Research in La Jolla, California, which was awarded $67 million to create the Center for Antiviral Medicines and Pandemic Preparedness.

Jung and Stauffer are receiving a combined $3.28 million for their projects. The team's goal is to create drugs aimed at targeting viruses with high pandemic potential — specifically coronaviruses and tick-borne viruses, according to a release.

Being part of that research collaborative is "hugely prestigious," Erzurum said.

"They trust us to be part of that network," she said. "A lot of it is on COVID, but it's also on the tick-borne viruses, right? And monkeypox is here."

With infectious disease, Jung said, today's patient could be tomorrow's 100 patients, or 1,000.

"This is the reason that with infectious disease as well as other medical data research … we cannot stop," he said, comparing it to running a marathon. "And when you run a marathon, if you stop it's so very difficult to then restart that marathon, so we have to continuously expand the program."

Thu, 13 Oct 2022 06:42:00 -0500 en text/html https://www.crainscleveland.com/health-care/cleveland-clinics-pathogen-center-continues-its-growth
Killexams : IBM’s former CEO downplays the importance of a college degree for six-figure earning ‘new collar’ jobs that now make up half of its workers

A four-year bachelor’s degree has long been the first rung to climbing America’s corporate ladder.

But the move to prioritize skills over a college education is sweeping through some of America’s largest companies, including Google, EY, Microsoft, and Apple. Strong proponents say the shift helps circumvent a needless barrier to workplace diversity.

“I really do believe an inclusive diverse workforce is better for your company, it’s good for the business,” Ginni Rometty, former IBM CEO, told Fortune Media CEO Alan Murray during a panel last month for Connect, Fortune’s executive education community. “That’s not just altruistic.”

Under Rometty’s leadership in 2016, tech giant IBM coined the term “new collar jobs” in reference to roles that require a specific set of skills rather than a four-year degree. It’s a personal commitment for Rometty, one that hits close to home for the 40-year IBM veteran.

When Rometty was 16, her father left the family, leaving her mother, who’d never worked outside the home, suddenly in the position to provide.

“She had four children and nothing past high school, and she had to get a job to…get us out of this downward spiral,” Rometty recalled to Murray. “What I saw in that was that my mother had aptitude; she wasn’t dumb, she just didn’t have access, and that forever stayed in my mind.”

When Rometty became CEO in 2012 following the Great Recession, the U.S. unemployment rate hovered around 8%. Despite the influx of applicants, she struggled to find employees who were trained in the particular cybersecurity area she was looking for.

“I realized I couldn’t hire them, so I had to start building them,” she said.

In 2011, IBM launched a corporate social responsibility effort called the Pathways in Technology Early College High School (P-TECH) in Brooklyn. It’s since expanded to 11 states in the U.S. and 28 countries.

Through P-TECH, Rometty visited “a very poor high school in a bad neighborhood” that received the company’s support, as well as a community college where IBM was offering help with a technology-based curriculum and internships.

“Voilà! These kids could do the work. I didn’t have [applicants with] college degrees, so I learned that propensity to learn is way more important than just having a degree,” Rometty said.

Realizing the students were fully capable of the tasks that IBM needed moved Rometty to return to the drawing board when it came to IBM’s own application process and whom it was reaching. She said that at the time, 95% of job openings at IBM required a four-year degree. As of January 2021, less than half do, and the company is continuously reevaluating its roles.

For the jobs that now no longer require degrees and instead rely on skills and willingness to learn, IBM had always hired Ph.D. holders from the very best Ivy League schools, Rometty told Murray. But data shows that the degree-less hires for the same jobs performed just as well. “They were more loyal, higher retention, and many went on to get college degrees,” she said.

Rometty has since become cochair of OneTen, a civic organization committed to hiring, promoting, and advancing 1 million Black individuals without four-year degrees within the next 10 years.

If college degrees no longer become compulsory for white-collar jobs, many other qualifications—skills that couldn’t be easily taught in a boot camp, apprenticeship program, or in the first month on the job—could die off, too, University of Virginia Darden School of Business professor Sean Martin told Fortune last year.

“The companies themselves miss out on people that research suggests…might be less entitled, more culturally savvy, more desirous of being there,” Martin said. Rather than pedigree, he added, hiring managers should look for motivation.

That’s certainly the case at IBM. Once the company widened its scope, Rometty said, the propensity to learn quickly became more of an important hiring factor than just a degree.

This story was originally featured on Fortune.com

More from Fortune:

A 2007 flashback: home flippers are in trouble again

Managing Gen Z is like working with people ‘from a different country’

The Renault Nissan empire once held together by fugitive Carlos Ghosn may slowly be unraveling

PayPal tells users it will fine them $2,500 for misinformation, then backtracks immediately

Sun, 16 Oct 2022 06:27:00 -0500 en-US text/html https://finance.yahoo.com/news/ibm-former-ceo-downplays-importance-165139880.html
Killexams : Cybersecurity Issues in Healthcare: latest Trends and Solution

As treasure troves of sensitive patient data and providers of many crucial services, healthcare entities face significant and continued cyber risks from threat actors seeking to land a payday or cause disruption. This article takes a look at some of the prevailing cybersecurity issues in healthcare along with proposed ways to deal with them at both the government and organization levels.

Current Cybersecurity Issues in Healthcare

First, it’s worth looking at some latest statistics to deliver a snapshot of the current cyber threat landscape in healthcare. A 2022 IBM report found that healthcare is the 6th most attacked industry (up one place from 7th in the previous year). This increase in attacks is interesting when contrasted with the fact that total breaches along with individuals affected declined in the first half of 2022.

Data breaches might be on the decline, but it’s clear that healthcare continues to face significant cyber risks. Let’s now take a deeper dive into some of the current cybersecurity issues in healthcare.

Ransomware Not Going Away

The same IBM report referenced in the introduction to this section found that ransomware accounts for a far higher percentage of cyberattacks (38%) in healthcare than in most other industries. Ransomware is not going away as one of the dominant cybersecurity issues in healthcare because threat actors perceive healthcare providers as far more likely to pay up.

Double extortion tactics can prove particularly fruitful in healthcare. Before encrypting files, threat actors exfiltrate sensitive patient data and hold them to ransom with the threat of publishing the data on the dark web or reselling it if the provider doesn’t pay up.

Some gangs have even moved on to triple extortion where the threat of a DDoS attack adds more incentive to deliver in to ransom demands. Healthcare providers have a low tolerance for downtime in their critical IT systems because operations and even human safety can depend on these systems being online. The crux of the story is that ransomware attacks on healthcare providers aren’t going away any time soon.

Account Compromise

Account compromise is a growing problem that increases in line with the number of different applications, services and IT resources that healthcare employees require access to. The human element in cyberattacks plays a prominent role, with compromised accounts providing access to any and all of the resources belonging to the owner of a specific account. These compromises come from brute force hacks, phishing scams that dupe people into disclosing passwords, and the use of stolen credentials purchased or downloaded from dark web data leak sites.

In the perennial battle between security and user experience, the latter often wins the day in healthcare, where workflow disruptions for healthcare professionals can cause delays in patient treatment. What then happens is that employees get granted blanket access to resources without any contextual risk-based restrictions. Potential account compromises in an IT environment of lax access controls are data breaches waiting to happen.

Attacks on Smaller Healthcare Providers

A worrying latest cybersecurity issue in healthcare is a shift in the focus of cybercriminals toward smaller healthcare companies and specialty clinics. These smaller entities could include small physiotherapy clinics, ophthalmologists or even business associates that handle healthcare data (such as software vendors).

There are several possible reasons for targeting smaller healthcare providers; the most obvious being a perception of weak cyber defenses versus larger providers that are likely to invest more heavily in their cybersecurity programs.

Another factor potentially at play is that hitting a small local company with only a few patients is not going to garner as much media or law enforcement spotlight as more high-profile breaches. Eye Care Leaders, a software provider for eyecare practices, suffered a data breach that impacted over two million people, and this incident attracted a lot of media attention. Expect this trend to continue going forward as smaller healthcare companies with less cybersecurity expertise get targeted.

Medical Device Security Concerns

Medical device security continues to pose headaches for technology executives at healthcare companies. One concern is that many companies rely on legacy medical devices that never had any security built into them in the first place. These legacy devices could be exploited during a cyberattack, with implications for patient health.

Another concern is the proliferation of medical Internet of Things (IoT) devices within healthcare IT environments. These devices can transmit useful information about the state of important systems such as MRI scanners. Other IoT devices such as IoT pumps are used at patients’ bedsides to precisely deliver drugs and fluids; security flaws could endanger patients. A shocking finding exemplifying this threat is that 53% of connected medical devices have critical security vulnerabilities.

Proposed Solutions

So, what’s being done to address healthcare’s dominant modern cybersecurity challenges? Here are four proposed solutions that cover both government input and strategies that healthcare providers can enact autonomously.

Healthcare Cybersecurity Act of 2022

With healthcare being designated as one of the United States’ 16 Critical Infrastructure Sectors by CISA, its protection from cyber threats is clearly a national priority. An interesting development is a new proposed bill, the Healthcare Cybersecurity Act of 2022. This bill directs a collaborative effort between CISA and the U.S. Department of Health and Human Services to reduce cybersecurity attacks and data breaches in healthcare and public health.

Along with its mandate for collaboration between CISA and the HHS, the bill also requires CISA to conduct a comprehensive study outlining key cybersecurity risks facing the healthcare sector. In coordination with private sector experts, CISA also must provide training to asset owners and operators on cybersecurity risks and ways to mitigate them.

Another important directive in the bill is for CISA to assess healthcare cybersecurity workforce shortages and offer recommendations for addressing these shortages. Overall, this act is a significant move toward enhancing cybersecurity across healthcare from the top down.

FDA Medical Device Guidance

Another important development during 2022 was the release of FDA medical device cybersecurity guidelines. The documentation provides manufacturers with principles on which to base the design of cyber-secure medical devices for today’s interconnected healthcare environments containing more devices than ever. Even for devices that don’t require pre-market submission to the FDA, healthcare providers should refer to these guidelines when procuring medical devices for use within their environments.

The full guidance is quite substantial, but the main principles outlined for robust medical device security are:

  1. Ensuring that cybersecurity is a part of device safety
  2. Achieving security by design by meeting objectives around integrity, authorization, availability and confidentiality.
  3. Transparency for users (e.g., healthcare providers or patients) into the device’s cybersecurity controls, potential risks and other relevant information
  4. Scaling the required cybersecurity design and documentation in premarket submissions based on the cybersecurity risks of a given device

The publication of this guidance is a vital development in minimizing the risks to healthcare environments in light of the proliferation of diverse medical devices and the frequent electronic exchange of medical device-related health information.

Movements to Zero Trust Architecture

To cope better with considerable account compromise risks, healthcare organizations, (particularly large providers) should consider migrating to zero trust architecture. This architecture removes any implicit trust given to users on the network and assumes a threat actor is always lurking.

With zero trust, access to resources is dynamically and continually authenticated based on the identity and context of each request. A policy engine typically makes access request decisions on a per-session basis by calculating a trust score (via an algorithm). Implementing zero trust in healthcare environments reduces the threat of account compromise and associated breaches of sensitive patient records, medical devices, and applications.

Outsource Security Operations

Since threat actors have turned more of their attention to smaller and midsize healthcare providers, outsourcing security operations is a path worth exploring. The ability to cope with growing cyber threats is hampered by resource constraints that larger providers don’t suffer from as much. Other pressing business priorities can further limit the attention that cybersecurity gets in smaller organizations.

Outsourcing security operations can provide the necessary detection and response capabilities required for deterring and mitigating cyber threats. Managed providers use teams of experts to run their own security operations centers, fine-tune SIEM systems and monitor IT environments (endpoints, firewalls, etc.) at scale. Augmenting in-house security with outside resources that would otherwise be too costly or unavailable provides the best chance of giving smaller organizations the proactive initiative in dealing with cyber threats to their systems.

The post Cybersecurity Issues in Healthcare: latest Trends and Solution appeared first on Nuspire.

*** This is a Security Bloggers Network syndicated blog from Nuspire authored by Team Nuspire. Read the original post at: https://www.nuspire.com/blog/cybersecurity-issues-in-healthcare-recent-trends-and-solution/

Thu, 13 Oct 2022 07:28:00 -0500 by Team Nuspire on October 13, 2022 en-US text/html https://securityboulevard.com/2022/10/cybersecurity-issues-in-healthcare-recent-trends-and-solution/ Killexams : BigBear.ai Names Former IBM Executive Mandy Long as Chief Executive Officer

The MarketWatch News Department was not involved in the creation of this content.

COLUMBIA, Md., (BUSINESS WIRE) -- BigBear.ai (NYSE: BBAI), a leader in AI-powered analytics and cyber engineering solutions, today announced that the Board of Directors has appointed former IBM executive Amanda “Mandy” Long as Chief Executive Officer and member of the Board of Directors, effective October 12, 2022. Dr. Reggie Brothers will step down as Chief Executive Officer and from the Board of Directors, transitioning to serve as a Company advisor and Operating Partner at AE Industrial Partners.

Long joins BigBear.ai with 15 years of experience in software and hardware across multiple industries, most recently as an executive at IBM, where she successfully led organizations to launch multiple first-of-their-kind products and made significant contributions to the rapid growth of the IBM Watson artificial intelligence (AI) franchise. During her tenure at IBM, Long had full P&L responsibility for several large and complex global businesses, developing strategies to drive customer adoption of AI and other automation solutions. Long also played a key leadership role in IBM’s organizational transformation, leading the integration and optimization of new business lines for acquired assets, and introducing scalable operational processes, diverse talent curation and retention strategies, and pipeline management strategies.

“Mandy has an impressive record of building global technology portfolios and driving revenue growth and adoption of AI products. She has extensive M&A experience, deep software product experience in regulated and unregulated industries, and has implemented innovative and collaborative workplace environments at scale. With Mandy at the helm, we expect to accelerate BigBear.ai’s ability to bring AI-based products to both Commercial and Federal markets as the Company transitions from a premier services and solutions provider to a technology-led, multi-market leader in AI,” said Peter Cannito, Chairman of the BigBear.ai Board of Directors.

Cannito continued, “Reggie has been instrumental in creating the BigBear.ai vision of putting the power of AI into the hands of decision makers to Excellerate visibility, predictability, and outcomes for critical missions. We are grateful for his leadership in establishing BigBear.ai as a public company, building an experienced and resilient team, and bringing the Company to this point in its lifecycle.”

“I am honored to be named CEO of BigBear.ai, a dynamic company whose technology and expertise is trusted to solve so many critical challenges for our customers – from protecting our nation to helping hospitals deliver the right care at the right time to children who need it most,” said Long. “The opportunity to support the Company in productizing our unique technology assets, scaling into a market leader, and capitalizing on the rapidly growing demand for AI /ML solutions in every sector is a dream come true.”

Executive Bio

Mandy Long previously served as Vice President, IBM IT Automation and Vice President, IBM Integration & Application Platform. Prior to that, she served as General Manager, IBM Watson Health Provider Analytics, as well as Chief Product and Strategy Officer, Artificial Intelligence for IBM Watson. She also previously held Vice President of Product Management positions at Modernizing Medicine and Experian Health. Mandy has received multiple awards and recognition for her accomplishments in the fields of Healthcare IT, including as one of the Most Powerful Women in Healthcare IT from Health Data Management in 2017. She earned a B.A. in Economics from Connecticut College.

About BigBear.ai

BigBear.ai delivers AI-powered analytics and cyber engineering solutions to support mission-critical operations and decision-making in complex, real-world environments. BigBear.ai’s customers, which include the US Intelligence Community and Department of Defense, as well as customers in manufacturing, healthcare, commercial space, and other sectors, rely on BigBear.ai’s solutions to see and shape their world through reliable, predictive insights and goal-oriented advice. Headquartered in Columbia, Maryland, BigBear.ai is a global, public company traded on the NYSE under the symbol BBAI. For more information, please visit: https://bigbear.ai/ and follow BigBear.ai on Twitter: @BigBearai.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221011006085/en/

SOURCE: BigBear.ai

Tyler Sigmon

Paul Caminiti/Delia Cannan/Pam Greene


Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright Business Wire 2022

The MarketWatch News Department was not involved in the creation of this content.

Tue, 11 Oct 2022 08:30:00 -0500 en-US text/html https://www.marketwatch.com/press-release/bigbearai-names-former-ibm-executive-mandy-long-as-chief-executive-officer-2022-10-11
Killexams : IBM Expands Partner Access To Training Resources

Channel programs News

Wade Tyler Millward

“We can‘t be essential unless our partners are skilled in our products and confident in going to their clients with our products and selling them with us and for IBM,” IBM channel chief Kate Woolley said.


IBM has started giving registered members of its PartnerWorld program access to the training, badges and enablement IBM sales employees get along with a new learning hub for accessing materials.

The expansion is part of the Armonk, N.Y.-based tech giant’s investment in its partner program, IBM channel chief Kate Woolley told CRN in an interview.

“We can‘t be essential unless our partners are skilled in our products and confident in going to their clients with our products and selling them with us and for IBM,” said Woolley (pictured), general manager of the IBM ecosystem.

[RELATED: Channel Chief Kate Woolley: ‘No Better Time To Be An IBM Partner’]

Partners now have access to sales and technical badges showing industry expertise, according to a blog post Tuesday. Badges are shareable on LinkedIn and other professional social platforms. IBM sales representatives and partners will receive new content at the same time as it becomes available.

“This is the next step in that journey in terms of making sure that all of our registered partners have access to all of the same training, all of the same enablement materials as IBMers,” Woolley told CRN. “That’s the big message that we want people to hear. And then also in line with continuing to make it easier to do business with IBM, this has all been done through a much improved digital experience in terms of how our partners are able to access and consume.”

Among the materials available to IBM partners are scripts for sales demonstrations, templates for sales presentations and positioning offerings compared to competitors, white papers, analyst reports and solution briefs. Skilling and enablement materials are available through a new learning hub IBM has launched.

“The partners are telling us they want more expertise on their teams in terms of the IBM products that they‘re able to sell and how equipped they are to sell them,” Woolley said. “And as we look at what we’re hearing from clients as well, clients want that. … Our clients are saying, ‘We want more technical expertise. We want more experiential selling. We want IBM’ – and that means the IBM ecosystem as well – ‘to have all of that expertise and to have access to all the right enablement material to be able to engage with us as clients.’”

The company has doubled the number of brand-specialized partner sellers in the ecosystem and increased the number of technical partner sellers by more than 35 percent, according to IBM.

The company’s latest program changes have led to improved deal registration and introduced to partners more than 7,000 potential deals valued at more than $500 million globally, according to IBM. Those numbers are based on IBM sales data from January 2022 to August.

Along with the expanded access to training and enablement resources, Woolley told CRN that another example of aligning the IBM sales force and partners was a single sales kickoff event for employees and partners. A year ago, two separate events were held.

“I want our partners to continue to feel and see this as a big investment in them and representative of how focused we are on the ecosystem and how invested we are,” she said.

Wade Tyler Millward

Wade Tyler Millward is an associate editor covering cloud computing and the channel partner programs of Microsoft, IBM, Red Hat, Oracle, Salesforce, Citrix and other cloud vendors. He can be reached at wmillward@thechannelcompany.com.

Tue, 04 Oct 2022 07:15:00 -0500 en text/html https://www.crn.com/news/channel-programs/ibm-expands-partner-access-to-training-resources
Killexams : Better Buy: IBM Stock vs. 2-Year Treasury Notes

Investors this year increasingly turned away from dividend stocks in favor of the rising yields being offered on bonds. Given that investors can now earn a 4.3% return on a 2-year Treasury note, many prefer that guaranteed return to the risks of putting money into the stock market.

International Business Machines (IBM 1.74%) offers a dividend yield that exceeds that bond return. But with a bear market in progress, are investors better served to take a chance on the cloud stock or to take the 4.3% return at virtually zero risk?

IBM and its dividend

IBM didn't participate in the bull market of the 2010s. The stock dropped as its tech businesses suffered a considerable growth slowdown. In an effort to change that, IBM pivoted into the cloud computing sector aggressively, in part via its $34 billion purchase of Red Hat in 2019. Grand View Research forecasts a compound annual growth rate of 16% through 2030 for the cloud industry. Growth like that could certainly help both IBM and its stock.

Also, IBM spun off its managed infrastructure business into a new public company, Kyndryl. This business was less of a fit with the parent company amid its pivot to the cloud. Separating it off should make it easier for IBM to grow its revenue.

Time will tell if these moves can help the stock price recover. Nonetheless, IBM currently pays its shareholders $1.65 per share every quarter, or $6.60 per share annually. At the current stock price, that adds up to a yield of 5.6% per year. Moreover, depending on your financial situation, the IRS may tax your dividends at a lower capital gains rate, which can offer an added advantage.

Additionally, IBM hiked its payout annually for 27 consecutive years, making it a Dividend Aristocrat. That status carries some importance as many income investors will be more inclined to buy and hold IBM stock because of this status. Also, since abandoning Dividend Aristocrat status tends to hurt a stock, management will probably prioritize maintaining it by continuing to raise those payouts.

Investors also can also reinvest their dividend payments into more IBM stock. However, such newly purchased shares will pay you the dividend yield at that time. The return will rise if the stock falls since investors can buy the exact cash return at a lower price. Conversely, cash yields will drop if the stock rises, but those investors still benefit since the stock has increased in value.

What to know about 2-year Treasury notes

U.S. Treasury notes offer more stability than stocks such as IBM. Investors who purchase the 2-year Treasury note receive semiannual interest payments. At the current interest rate of 4.3%, investors will receive a 2.15% cash return on their invested amount in each of the subsequent three six-month periods. In the fourth period, when the note matures, investors receive the final 2.15% payment along with the return of their principal.

Investors should also be aware that bond values can fluctuate. If interest rates drop, the value of the bond will fall; the opposite will happen if rates rise. This affects investors if they decide to sell the bond early. Upon maturity, the note will return to its par (or nominal) value.

Additionally, bond interest payments are subject to federal income tax but exempt from state and local taxes. In some cases, this is higher than taxes on dividends. Still, bond issuers are obligated to make such payments. In contrast, IBM faces no legal obligation to continue its dividend.

Also, like with a stock, investors can reinvest their interest payments into more notes or other forms of Treasury bonds. However, those purchases will be subject to the prevailing interest rates at that time.

IBM or the 2-year Treasury note?

Investors who lack much risk tolerance should choose the Treasury note. Given its guaranteed return, they will not have to worry about volatility.

Nonetheless, for investors comfortable with buying stocks, IBM is a surprisingly strong buy. The cloud industry is in growth mode, which should propel IBM stock to a long-awaited turnaround. Moreover, IBM has repeatedly shown it wants to hold on to its Dividend Aristocrat status. This should deliver its income investors returns that are not only larger than the bonds offer, but also likely to increase in size.

Will Healy has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Fri, 14 Oct 2022 00:20:00 -0500 Will Healy en text/html https://www.fool.com/investing/2022/10/14/better-buy-ibm-stock-vs-2-year-treasury-note/
Killexams : IBM Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on IBM IBM.

And retail traders should know.

We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with IBM, it often means somebody knows something is about to happen.

So how do we know what this whale just did?

Today, Benzinga's options scanner spotted 11 uncommon options trades for IBM.

This isn't normal.

The overall sentiment of these big-money traders is split between 27% bullish and 72%, bearish.

Out of all of the special options we uncovered, 7 are puts, for a total amount of $1,280,392, and 4 are calls, for a total amount of $243,682.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $105.0 to $165.0 for IBM over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for IBM's options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of IBM's whale activity within a strike price range from $105.0 to $165.0 in the last 30 days.

IBM Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
IBM PUT TRADE NEUTRAL 12/16/22 $115.00 $905.6K 351 1.8K
IBM CALL SWEEP BULLISH 06/21/24 $125.00 $151.2K 27 120
IBM PUT SWEEP BEARISH 01/20/23 $125.00 $113.7K 4.0K 5
IBM PUT SWEEP BEARISH 10/14/22 $120.00 $70.6K 816 322
IBM PUT TRADE BULLISH 01/19/24 $165.00 $64.4K 53 13
Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
IBM PUT TRADE NEUTRAL 12/16/22 $115.00 $905.6K 351 1.8K
IBM CALL SWEEP BULLISH 06/21/24 $125.00 $151.2K 27 120
IBM PUT SWEEP BEARISH 01/20/23 $125.00 $113.7K 4.0K 5
IBM PUT SWEEP BEARISH 10/14/22 $120.00 $70.6K 816 322
IBM PUT TRADE BULLISH 01/19/24 $165.00 $64.4K 53 13

Where Is IBM Standing Right Now?

  • With a volume of 2,052,099, the price of IBM is up 1.05% at $118.99.
  • RSI indicators hint that the underlying stock may be approaching oversold.
  • Next earnings are expected to be released in 8 days.

What The Experts Say On IBM:

  • Morgan Stanley has decided to maintain their Overweight rating on IBM, which currently sits at a price target of $152.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for IBM, Benzinga Pro gives you real-time options trades alerts.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Tue, 11 Oct 2022 13:56:00 -0500 text/html https://www.benzinga.com/markets/options/22/10/29224106/ibm-whale-trades-spotted
Killexams : IBM merges its data storage offerings with Red Hat’s OpenShift and Ceph

IBM Corp. is making some big changes to its data storage services, announcing today that it will bring Red Hat Inc.’s storage products and associates under the “IBM Storage” umbrella.

The aim, IBM said, is to deliver a more consistent application and data storage experience across on-premises and cloud infrastructures. It’s a big move that will see IBM Spectrum Fusion data management software adopt the storage technologies of Red Hat’s OpenShift Data Foundation as its new base layer.

Even more interesting, perhaps, is that the open-source Red Hat Ceph Storage offering will be transformed into a new IBM Ceph storage offering. IBM said this will result in a unified, software-defined storage platform that’s better able to bridge the architectural divide between data centers and cloud computing providers.

The computing giant said the move is in line with its software-defined storage strategy of a “born in the cloud, for the cloud” approach that will unlock bidirectional application and data mobility based on a shared, secure and cloud-scale solution.

IBM Systems General Manager of Storage Denis Kennelly said the shift is designed to streamline the two companies’ portfolios. “By bringing together the teams and integrating our products under one roof, we are accelerating IBM’s hybrid cloud strategy while maintaining commitments to Red Hat’s customers and the open-source community,” he insisted.

The company presented the changes as a big win for customers, saying they will gain access to a more consistent set of storage services that preserve data resilience, security and governance across bare metal, virtualized and containerized environments. More specifically, IBM is promising that customers will have a more unified storage experience for container-based applications running on Red Hat OpenShift, with the ability to use IBM Spectrum Fusion, which is now based on Red Hat OpenShift Data Foundation. Doing so will provide higher performance, greater scale and more automation for OpenShift applications that require block, file and object access to data, the company said.

As for IBM Ceph, the company said this will deliver a more consistent hybrid cloud experience with enterprise-grade scale and resiliency.

Furthermore, by unifying IBM’s and Red Hat’s storage technologies, customers will be able to build a single data lakehouse on IBM Spectrum Scale to aggregate all of their unstructured data in one place. Benefits will include less time spent on maintenance, reduced data movement and redundancy, and more advanced schema management and data governance.

Industry watchers were united in their belief that the changes would be of benefit to customers. Steve McDowell of Moor Insights & Strategy told SiliconANGLE that today’s move makes a lot of sense because it enables IBM to leverage the storage strengths of both companies.

McDowell explained that although IBM Spectrum is considered to be one of the most comprehensive data management platforms around, its foundation predates the rise of cloud-native technologies. On the other hand, he said, Red Hat OpenShift was built from the ground up to support cloud-native workloads.

“IBM is evolving Spectrum Fusion to take the best of Red Hat’s efforts, and is using Red Hat’s storage software as the base for its IBM-branded products moving forward,” McDowell said. “It makes a lot of business sense for IBM to leverage R&D from Red Hat into its more traditionally proprietary systems. It also gives IBM an easy path to better serve the needs of containerized workloads.”

International Data Corp. analyst Ashish Nadkarni said the two companies are now “speaking with one voice on storage” and finally delivering on the synergies between them that were mentioned when IBM acquired Red Hat in 2019.

“The combining of the two storage teams is a win for IT organizations as it brings together the best that both offer: An industry-leading storage systems portfolio meets an industry-leading software-defined data services offering,” Nadkarni said. “This initiative enables IBM and Red Hat to streamline their family of offerings, passing the benefits to their customers.”

IBM also moved to reassure users of Red Hat’s open-source technologies that it will remain fully committed to them following today’s announcements. As part of the deal, IBM will take over Premier Sponsorship of the Ceph Foundation and, along with Red Hat’s teams, continue to drive innovation and development. Both IBM Ceph and Red Hat OpenShift will remain 100% open-source, the company added, and will continue to follow an upstream-first development model.

McDowell said today’s move would likely make some users nervous about the prospect of Red Hat’s technology becoming more proprietary over time. “IBM has been very careful since it acquired Red Hat in 2019 to keep Red Hat’s open-source business segregated from IBM’s branded offerings,” he said. “This is the first time we’re seeing IBM cross that that line, and it’s natural to wonder how blurred those lines will become.”

Still, McDowell said, he’s inclined to believe IBM’s promises as it has been very deliberate about keeping Red Hat’s storage technologies open-source.

“Red Hat OpenShift Data Foundation and Ceph will still be available as they always have, though its evolution will undoubtedly be more strongly guided by the needs of IBM’s storage business,” the analyst continued. “Overall this is a net positive for IBM and its customers. It makes good business sense and there should be minimal impact to Red Hat’s existing community.”

IBM said the first storage solutions to launch under the new IBM Ceph Storage and IBM Spectrum Fusion banners will arrive in the first half of 2023, so users will have plenty of time to digest the changes.

Image: Red Hat

Show your support for our mission by joining our Cube Club and Cube Event Community of experts. Join the community that includes Amazon Web Services and Amazon.com CEO Andy Jassy, Dell Technologies founder and CEO Michael Dell, Intel CEO Pat Gelsinger and many more luminaries and experts.

Wed, 05 Oct 2022 20:58:00 -0500 en-US text/html https://siliconangle.com/2022/10/04/ibm-merges-data-storage-offerings-red-hats-openshift-ceph/
000-052 exam dump and training guide direct download
Training Exams List